PSY19 A COST PER RESPONDER ANALYSIS OF SECUKINUMAB COMPARED TO OTHER BIOLOGICS FOR TREATMENT OF MODERATE TO SEVERE PSORIASIS PATIENTS OVER 1 YEAR IN MOROCCO
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.2647
https://www.valueinhealthjournal.com/article/S1098-3015(19)35025-9/fulltext
Section Title :
Section Order :
12325
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)35025-9&doi=10.1016/j.jval.2019.09.2647